T细胞通过IL-6/CD74轴促进小细胞肺癌的生长
bioRxiv : the preprint server for biology
|December 25, 2025
概括
令人惊的是,T细胞通过介质素-6 (IL-6) 信号传递促进小细胞肺癌的生长. 阻断IL-6可以提高免疫疗法的有效性,为这种侵袭性癌症提供了一种新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 免疫检查点抑制 (ICI) 的有效性和耐用性有限,特别是在小细胞肺癌 (SCLC) 中.
- 目前用于SCLC的化疗加ICI疗法很少有治愈作用.
- 更深入地了解SCLC中的瘤免疫相互作用至关重要.
研究的目的:
- 研究T细胞在小细胞肺癌 (SCLC) 进展中的作用.
- 确定T细胞影响SCLC生长的机制.
- 探索用于增强SCLC免疫治疗的新型治疗点.
主要方法:
- 利用SCLC的小鼠模型来研究T细胞功能.
- 分析了T细胞介导的细胞因子的产生,特别是IL-6 (IL-6).
- 研究了IL-6对SCLC细胞存活因子CD74表达的影响.
- 在人类SCLC瘤中相关的IL-6水平与患者生存结果.
- 在体内评估IL-6阻断与ICI结合的疗效.
主要成果:
- 在SCLC小鼠模型中,T细胞被发现是最佳瘤生长所必需和足够的.
- 瘤前作用是由T细胞衍生的IL-6介导的,它诱导了SCLC细胞中的CD74表达.
- 人类SCLC瘤显示T细胞IL-6表达,较低的IL-6信号与化疗后更好的患者存活率以及ICI相关.
- IL-6阻断与ICI协同作用,在体内抑制SCLC瘤生长.
结论:
- 在SCLC中,T细胞起着矛盾的作用,促进瘤的存活.
- 一个意想不到的T细胞IL-6-CD74轴驱动着SCLC的进展.
- 与ICI结合向IL-6代表了一种有前途的治疗策略,以改善SCLC的免疫治疗结果.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
15.2K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.8K
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
T Cell Activation and Clonal Selection
14.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K
